Gensler appointed to lead the design of London Cancer Hub

Aviva and Socius have appointed Gensler, a leading global architecture and design practice, to spearhead the design of a cutting-edge cancer research and treatment district at the London Cancer Hub (LCH) in Sutton.

Gensler, with over 6,000 designers worldwide, has a remarkable track record in delivering lab, R&D, and innovation facilities for biotech, pharmaceutical, and science-based industries globally. Their portfolio includes notable projects such as the Cure healthcare innovation campus in New York, the IQHQ Research and Development District in San Diego, and the US headquarters for Genmab in New Jersey.

The Largest Science Campus by Gensler in Europe

At 1 million sq ft, the London Cancer Hub will be Gensler's largest science campus in Europe. It will comprise state-of-the-art labs, R&D space, healthcare facilities, and supporting accommodation. The site will also include beautifully landscaped green spaces that integrate seamlessly with existing world-class facilities, such as the Institute of Cancer Research, the Royal Marsden Hospital, and the Innovation Gateway incubator.

Gensler aims to create a vibrant ecosystem at LCH, with an active ground floor that showcases innovation while supporting local employment opportunities in science-based industries. The development will target net-zero carbon in operation, exceeding current sustainability standards.

Gensler joins a distinguished project team that includes global engineering and sustainability consultancy Arup and the UK's largest planning consultancy, Savills.

Daniel May, Development Director, said: "Gensler has an unrivalled track record in designing buildings and places for scientific discovery, and we are excited to work with them as part of a world-class project team, including Arup and Savills. There is a unique opportunity at the London Cancer Hub to create a vibrant ecosystem of labs, R&D space, and healthcare facilities that will attract leading researchers and scientists from around the world to drive progress in cancer treatment and diagnostics, as well as inspire those who live, work, and study in the area."

Sophie White, Regeneration Lead at Aviva, added: "We are pleased to bring together this world-class team to design and develop the London Cancer Hub and advance the ambition to bolster the UK's leading role in the global life sciences sector. Aviva, alongside Socius, looks forward to partnering with local residents, businesses, and the Council to provide much-needed jobs, training opportunities, and wider community benefits."

Richard Harrison, Co-Managing Director and Principal at Gensler, commented: "The site boasts a prestigious group of institutions, but we envisage a more connected and truly inclusive innovative district that will bring leading talent and businesses together to revolutionise cancer research and treatment. At Gensler, we recognise the transformative power of design to elevate health and wellness and are proud to be working on a project that will help accelerate scientific discovery."